ischemically compromised (mismatch of reduced perfusion and maintained FDG uptake). Functional outcome was assessed by serial radionuclide ventriculography before and at 13±13 weeks (median interval of 8 weeks) after coronary revascularization. Preoperatively impaired regional wall motion improved significantly in ischemically compromised (mismatch) revascularized segments but not in nonviable myocardium or in viable myocardium without discordance of perfusion and metabolism. The negative predictive value of PET for functional recovery was 86%, whereas the positive predictive value in revascularized regions ranged from 48% to 86% depending on severity of baseline wall motion abnormalities.
Conclusions PET identifies metabolically active tissue, which benefits from revascularization. Although the negative predictive value of PET for recovery was high, functional improvement of viable but ischemically compromised tissue was less frequent than previously reported. The predictive value of PET was highest in left ventricular segments with severe dysfunction and a mismatch or reduced perfusion but preserved metabolism. Integration of PET, angiographic, and functional data is necessary for the optimal selection of patients with advanced coronary artery disease and impaired left ventricular function for revascularization. (Circulation. 1994; 90:2356 -2366 Key Words * revascularization * metabolism * tomography D espite remarkable advances in therapy, coronary artery disease remains a major health care problem in our society. With improved therapeutic approaches such as thrombolysis, more patients survive myocardial infarction but may subsequently present with congestive heart failure and recurrent ischemia. In addition, patients with previous revascularization suffer from progression of underlying coronary artery disease with a higher risk/benefit ratio for repeated revascularization procedures. Therefore, an increasing number of patients with advanced and complex coronary artery disease require medical attention.
The clinical and prognostic benefits of revascularization appear to be greatest in patients with extensive coronary artery disease and impaired left ventricular function.
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Several studies have addressed the predictive value of PET imaging for recovery of regional and global left ventricular function after coronary revascularization.5,10-15 Furthermore, the impact of PET imaging results, on clinical outcome and mortality in patients with coronary artery disease and evidence for ischemically compromised myocardium, has been reported recently. [16] [17] [18] [19] In addition to PET imaging of both perfusion and metabolism, an alternative approach using 9'Tc isonitriles and single photon emission tomography for assessment of perfusion in combination with metabolic imaging using FDG and PET has been evaluated. [20] [21] [22] However, in studies with follow-up assessment of left ventricular function, global ejection fraction, if reported, was normal or only slightly impaired at baseline, with the exception of the studies by Tillisch et al, 5 Carrel et al,13 and Lucignani et a121 and, therefore, represented a relatively "low-risk" subgroup of patients with coronary artery disease. Such patient selection may not fully account for the common clinical problem of selecting patients with advanced coronary artery disease and severely impaired left ventricular function for revascularization. In addition, most previous studies evaluated functional outcome based on "fixed" scintigraphic criteria, which were 
Assignment of Myocardial Regions and Revascularization
The procedure reports of coronary angiography and bypass surgery were reviewed for coronary anatomy and location of revascularization. The anterior and anterolateral walls were considered the revascularization territory of the left anterior descending coronary artery and its side branches. The lateral wall was designated the distribution territory of the left circumflex artery and posterolateral branches. The right coronary artery was assigned to the inferior and posterior walls. Depending on the coronary distribution type, the apex was assigned to either the left anterior descending or the right coronary artery. Thirty-seven patients (34 men, 3 women) with a mean age of 59±11 years, who fulfilled the inclusion criteria and could be followed postoperatively, completed the protocol. Twenty-seven patients (73%) had a documented previous myocardial infarction. Eleven of 27 patients were studied between 2 and 6 weeks after myocardial infarction and 18 patients more than 6 weeks after the acute event. Six patients (16%) had previous coronary angioplasty, and Table 2 illustrates the results of the analysis with regard to the predictive accuracy of tissue characterization by PET imaging for functional improvement of individual regions.
Absence of myocardial viability was highly predictive for absence of improvement, averaging 86%.
As expected from the results of mean wall motion analysis, the predictive accuracy for regions with preserved viability was different within the three subgroups as categorized by PET. For normal regions, prediction of improvement was 53% in regions with mild wall motion abnormalities at baseline and increased to 75% in those with marked dysfunction at baseline.
In regions with a mismatch of flow and glucose metabolism, there was a close relation between the severity of baseline wall motion and the prediction of functional recovery. The predictive accuracy was 48% for regions with mild hypokinesis and increased to 67% with more severe wall motion abnormalities at baseline. After exclusion of the apical segments, the positive predictive accuracy for recovery was 86% for the remaining left ventricular regions with mismatch.
Regions with evidence of preserved viability by mildly reduced perfusion and FDG uptake at baseline, but without a significant discordance between flow and metabolism, showed improvement at follow-up in only 21% to 31%.
Comparison of Perfusion and Metabolism With Functional Outcome
Fig 2 summarizes the relation between preoperative FDG uptake (Fig 2A), perfusion (Fig 2B) , and regional wall motion at follow-up for revascularized regions. In regions demonstrating normal glucose metabolism, function at follow-up was normal or nearly normal (<2) in 72% but severely hypokinetic or worse (.3) in only 7%. In contrast, in regions with markedly reduced metabolic activity (>3) at baseline, only 11% displayed mild hypokinesis or better wall motion (<2) at follow- As could be demonstrated above for regional function, the degree of global functional improvement was related to the severity of dysfunction at baseline. Twelve patients with an ejection fraction .30% benefited most from revascularization, with an increase from 23 ±6% to 28±7% (P<.01), which is illustrated in Fig 3A. In contrast, patients with a baseline ejection fraction >30% (Fig 3B) did not improve functionally after surgery (39±7% and 40±8%, P=NS). The difference in functional changes between those two groups was significant (P<.05).
Seven patients with a preoperative mismatch pattern by PET The results of this study confirm previous observations indicating that functional recovery of regional myocardial dysfunction after revascularization can be predicted by combined imaging of myocardial perfusion and metabolism with PET.5 15 Our study addressed for the first time the relation between the predictive value of various PET findings and the severity of baseline wall motion abnormalities. The predictive accuracy of metabolic imaging for functional outcome was high either for regions with severely reduced perfusion and metabolic activity or for those with evidence for preserved tissue viability in the presence of reduced [3N]ammonia uptake ("mismatch"). In contrast, the scintigraphic pattern with mild to moderate concordant decrease of flow and metabolism displayed a poor predictive value for functional recovery after revascularization. These findings support the concept of "hibernating" myocardium, which has been defined as myocardium with chronically reduced perfusion at rest but reversible functional impairment after revascularization.67 Regional PET evaluation of perfusion and FDG uptake allows for the unique identification of this form of ischemically compromised myocardium. Independent of these results, which define the predictive accuracy of various scintigraphic patterns for subsequent functional recovery, we and others have previously shown that patients with PET mismatch have a poor clinical prognosis without subsequent revascularization.6-18 Furthermore, Yoshida and Gould19 demonstrated that size of myocardial infarction or scar and myocardial viability in vascular territories at risk, assessed by PET imaging of 82Rb washout, were good prognostic indicators of 3-year mortality. All these observations suggest the clinical usefulness of PET in selecting patients with advanced coronary artery disease and impaired left ventricular function for revascularization.
There was close agreement between the data of this study and those of previous investigations, as far as the negative predictive value of metabolic imaging for functional changes is concerned. Concordantly reduced FDG uptake and perfusion were highly specific for scar tissue, The correlation of PET findings with regional wall motion as assessed by radionuclide ventriculography may not be ideal. PET represents a tomographic image modality, and the results were compared with radionuclide ventriculography in three planar views. Correlation of tomographic findings with those of radionuclide ventriculography is challenging, especially for the comparison of areas such as the left ventricular apex. Changes of activity on radionuclide ventriculograms represent volume changes and not true wall motion and may therefore be sensitive to overlap of opposing wall segments and passive motion. This technical difficulty may explain the low predictive value of PET, especially in apical segments of the left ventricle. Ideally, PET data should be correlated with functional high-resolution studies using tomographic approaches such as ever, no such data were available in the patient population studied.
Technical Considerations
In previously published investigations, PET using FDG has been performed either after oral glucose loading to identify glucose metabolism in hypoperfused myocardium,8,2930 under fasting conditions to detect the metabolic effects of myocardial ischemia after exercise or pharmacological stress testing10,31'32 or during continuous intravenous insulin/glucose clamping.33 Imaging with FDG is significantly affected by the dietary state due to glucose being only one of several substrates utilized by the myocardium. In this study, patients were imaged postprandially after an oral glucose load to enhance myocardial glucose utilization.29 This approach was supplemented by intravenous insulin in patients with proven or suspected diabetes mellitus, which has been shown to improve the diagnostic quality in this patient subpopulation. 34 PET images and radionuclide ventriculograms were independently analyzed by visual interpretation by two experienced investigators. This reflects clinical practice in many institutions, despite the availability of quantitative or semiquantitative analysis programs for the interpretation of perfusion studies. These programs rely on the normalization of regional myocardial tracer activity to a "normal" segment, which is defined as "highest tracer uptake" in perfusion imaging. Since FDG uptake may vary considerably in normal myocardium depending on the metabolic state,3536 standardization of tracer uptake has proved difficult. However, this limitation also accounts for visual analysis. Although approaches have been published with normalization of FDG uptake to regions with "normal" or highest perfusion,202237 no widely accepted and prospectively validated semiquantitative analysis approach is currently available for the evaluation of clinical FDG-PET studies. Visual interpretation with its inherent limitations is currently used in most PET laboratories for analysis of clinical FDG-PET viability studies.
Conclusions
Combined imaging of myocardial perfusion and metabolism using PET provides sophisticated tissue characterization in patients with advanced coronary artery disease and impaired left ventricular function. Absence of metabolic activity as assessed by regional FDG uptake was highly predictive for no functional change after revascularization, confirming previous reports about the high negative predictive value of metabolic imaging. The positive predictive value for tissue recovery based on FDG uptake alone was considerably lower in this study than reported previously. Combined evaluation of regional myocardial perfusion and FDG uptake is necessary to identify segments with reduced perfusion and relatively increased FDG uptake. Such a ''mismatch" pattern had a higher predictive value than FDG uptake or perfusion criteria alone. More importantly, the functional improvement and its prediction by combined PET imaging patterns was related to the severity of baseline myocardial dysfunction, indicating that the PET information should be used in context with wall motion analysis to maximize the predictive value cine-CT or gated magnetic resonance imaging. 
